BioNTech, Pfizer defeat Promosome Covid-19 vaccine patent lawsuit at UPC
By Inbar Preiss ( July 8, 2026, 12:24 GMT | Insight) -- BioNTech and Pfizer have defeated Promosome’s Unified Patent Court lawsuit over Comirnaty Covid-19 vaccines, with judges revoking the asserted mRNA-related patent in Germany, France and Sweden. The court found Promosome had standing to sue, but failed on validity and infringement.BioNTech and Pfizer have defeated a Unified Patent Court lawsuit brought by Promosome over the companies’ Comirnaty Covid-19 vaccines....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.